CN103055263A - External use plaster for treating breast hyperplasia - Google Patents
External use plaster for treating breast hyperplasia Download PDFInfo
- Publication number
- CN103055263A CN103055263A CN201310006173XA CN201310006173A CN103055263A CN 103055263 A CN103055263 A CN 103055263A CN 201310006173X A CN201310006173X A CN 201310006173XA CN 201310006173 A CN201310006173 A CN 201310006173A CN 103055263 A CN103055263 A CN 103055263A
- Authority
- CN
- China
- Prior art keywords
- parts
- plaster
- mixing
- add
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides an external use plaster for treating the breast hyperplasia. The main components of the plaster comprise Vaccaria segetalis, myrrh, Boswellia carteri, Chinese angelica, safflower, dragon's blood, borneol, Fructus Toosendan, Rhizoma Curcumae and the like, so the plaster has the lactation promoting, stagnation eliminating, blood circulation promoting and stasis dissolving functions. The plaster which is a medicine is different from previous schemes for simply treating the breast hyperplasia, is used through adopting an acupoint plastering method, and has the advantages of multilevel and multi-targeting, yin and yang balance, system adjustment, simultaneous treatment of principal and subordinate symptoms, unique treatment method, and curative effect reliability.
Description
Technical field
The present invention relates to a kind of external plaster for the treatment of cyclomastopathy.
Background technology
Breast disease is women's commonly encountered diseases, frequently-occurring disease, and it is difficult to control for a long time, and sickness rate is up to 80%, and the sickness rate of cyclomastopathy has reached more than 60% of the women of child-bearing age.In recent years, breast disease is in the peak period, and canceration rate is very high, current research according to Chinese traditional Chinese medical science breast disease study on prevention center epidemiology statistics is found, the female mammary gland cancer morbidity has increased by 39% in recent years, and age of onset has shifted to an earlier date 10 years old, gradually in rejuvenation, breast carcinoma is leapt to the first by several years ago the 5th on the ranking list of female tumor, becomes the No.1 killer of women's health.The patient who often runs into many cyclomastopathy in clinical is for this reason weighed down with anxieties, thinks that cyclomastopathy also is incurable disease, controls badly, does not remove root, cyclomastopathy really one easily examine, refractory, the easy disease of recurrence.At present to the treatment of primary disease mostly adopt hormone medicine, the method treatment such as have an operation, but DeGrain.
Summary of the invention
The purpose of this invention is to provide a kind of external plaster for the treatment of cyclomastopathy, this plaster curative effect is high, and expense is low, and is easy to use simple and direct, has no side effect, and does not recur after healing.
The present invention treats the external plaster of cyclomastopathy and is made by weight by following bulk drugs:
80~110 parts of Semen Vaccariae, 50~75 parts of Myrrhas, 50~75 parts of Olibanums, 60~80 parts of Radix Angelicae Sinensis, 60~80 parts on Flos Carthami, 40~55 parts of Sanguis Draxonis, 65~90 parts of Fructus Toosendans, 75~95 parts of Rhizoma Curcumae, 30~50 parts of Cornu Cervi Degelatinatums, 50~70 parts on Pericarpium Citri Reticulatae Viride, 60~80 parts of Rhizoma Bolbostematiss, 60~80 parts of Radix Phytolaccaes, 20~40 parts of Borneolum Syntheticums, 10~20 parts of laurocaprams, 150~250 parts of refined honeys, 100~250 parts of lanolines, 70~150 parts of propylene glycol.
The preparation method of this plaster is as follows:
Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder are broken into fine powder (100 mesh sieve), mixing, for subsequent use; The decocting that Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate is concentrated into relative density 1.20~1.25(60 ℃) clear paste; After refined honey, lanoline, the propylene glycol heating melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45~55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
The present invention adopts root, stem, leaf flower, fruit, the seed of Chinese herbal medicine, through cleaning the techniques such as oven dry, under defined terms, with the Chinese medicine preparation technology Chinese herbal medicine is ground into respectively fine powder and is extracted into extractum, form this emplastrum by proportioning blending mixing, easy to use, in proper order blood pressure lowering, stable curative effect, thorough treatment, without any side effects, the main outer treatment cyclomastopathy that is used for.
Characteristics of the present invention
1, tcm characteristic: external treatment of Chinese medicine is under the theory of Chinese medical science determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs instructs viscera, meridians, QI and blood to be carried out integrally-regulated process.Be again to make medicine and physical agent directly act on quickly diseased region, produce the process of curative effect by dermal osmosis, mucosa absorption, acupoint stimulation etc.Chinese medicine external medicine direct effect diseased region skin.Transdermal effect by medicine reaches high drug level at diseased region, can remedy some deficiency of endo-medicine, with reach circulation of qi promoting, invigorate blood circulation, blood stasis dispelling, eliminating stagnation, thereby effectively remove symptom, and have letter, just, effect, honest and clean, the characteristics that have no side effect.
2, medicine directly imposes on the affected part, and the transdermal technology is used the Transdermal absorption that has also increased medicine, and these all are the reasons that this plaster treatment cyclomastopathy condition of disease obtains satisfied curative effect.Transdermal absorption, medicine are directly infiltrated focus deep skin tissue.Avoid the loss of medication amount and to human viscera organ's poisoning.Use its external application, penetration power is strong, can make local organization relax, unfold, and improves blood circulation, strengthens cell viability, thereby reaches rapidly the purpose of blood circulation promoting and blood stasis dispelling, lactogenesis eliminating stagnation, anti-inflammatory analgesic.Its external can improve blood circulation, strengthens cell viability, and the regeneration capacity of fortifying fibre and blood capillary promotes tissue regeneration, thereby reaches the purpose of detumescence, softening the hard mass, eliminating stagnation.
3, product is through a large amount of clinical verifications, and it is to epiderm skin tissue, subcutaneous tissue not damaged, and nonirritant has no side effect.Sum up for many years clinical experience and the gains in depth of comprehension cyclomastopathy plaster therapy of creating out simple and direct practicability and effectiveness, the regulation and control equilibrium between yin and yang is until basic rehabilitation and hold stable for a long time; Thoroughly radical cure does not need Long-term taking medicine, after the Gene regulation in the medicine and the bioactive molecule in the plant enter human body, activates and also regulates disorderly hormonal system, makes it be tending towards normal secretion.The above clinical observation on the therapeutic effect result who does shows, adopts plaster external ruling by law to treat cyclomastopathy, have short treating period, instant effect, curative effect high, have no side effect, the advantages such as no pain, convenience, satisfactory effect, the patient also is easy to acceptance.
Below be to adopt plaster treatment cyclomastopathy 55 examples, obtained comparatively satisfied curative effect.Now be reported as follows.
1. clinical data
1.1 physical data
Cyclomastopathy patient 55 examples all meet the cyclomastopathy diagnostic criteria; 23~54 years old age, average 32.5 years old; The course of disease 2~15 years, average 8 years.Clinical manifestation bilateral breast hypertrophy 18 examples (32.7%), one-sided cyclomastopathy 33 examples (67.3%), mastalgia 53 examples (96.4%).
1.2 diagnostic criteria
(1) the strip lump appears in breast, is primary symptom with the periodicity distending pain of the breast how; (2) palpation has streak lump, can promote; (3) prompting of galactophore scanning analyzer is A type or Type B blood vessel II~III degree ghost.
2. Therapeutic Method
2.1 efficacy assessment standard
Cure: the equal complete obiteration of pain and enclosed mass, drug withdrawal was not recurred in 3 months; Produce effects: the lump maximum gauge dwindles more than 1/2, and mastalgia alleviates; Effectively: the lump maximum gauge dwindles less than more than 1/2, and mastalgia alleviates; Invalid: lump does not dwindle or increases on the contrary hardening person, or simple mastalgia is alleviated and lump does not dwindle.
2.2 Therapeutic Method
55 routine patients all adopt strapping treatment, during use plaster are spread on the affected part, change medicine every day one time, and 15~20 days is a course for the treatment of, the other drug of stopping using during the treatment, and after patient's medication 2 courses for the treatment of, drug withdrawal check in 3 months.A situation arises to note simultaneously observing untoward reaction during medication.
3. therapeutic outcome
In 55 examples, cure 45 examples, wherein treat 1 the courses for the treatment of 23 example, treat 2 the courses for the treatment of 22 example; Produce effects 6 examples; Effective 2 examples; Invalid 2 examples.Total effective rate 96.4% is not found obvious adverse reaction during the medication.
4. discuss
Plaster is by the through focus of the subcutaneous infiltration of liniment, and the acceleration blood circulation progressively softens the lump of hypertrophy, decomposes, absorbs, thereby reaches the purpose for the treatment of both the principal and secondary aspects of a disease.Through clinical practice, its treatment cyclomastopathy total effective rate 96.4% is not found untoward reaction.
Effect of the present invention
External treatment is an important component part in the Chinese medicine, with Chinese medicine percutaneous skin, acupuncture points on the human body, face nine orifices osmotic absorption and reach therapeutic purposes, have letter, just, honest and clean, the characteristics such as test, without toxic and side effects such as gastrointestinal reaction and hepatorenal damages, showed good prospect for the treatment primary disease, significant for the primary prevention of breast carcinoma.The unique distinction of plaster shows: the one, and by arterial channel, the 2nd, by hydration, the 3rd, by Action of Surfactant, the 4th, by the facilitation of aromatic herbs.The external therapy of Chinese herb indirect action is except dispenser, also has auxiliary warm stimulation, chemical stimulation and mechanical-physical to stimulate, and to accelerate blood circulation, promotes infiltration, absorption and the propagation of medicine and strengthens systemic effect.The external application of Chinese medicine can act on each system in the body by the relevant approach with internal organs through the cave, and play the Accommodation of multisystem, many organs, too many levels in acupuncture points on the human body.
Description of drawings
Fig. 1 is the production technological process of plaster.
The specific embodiment
Embodiment 1 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 100g, Myrrha 60g, Olibanum 60g, Radix Angelicae Sinensis 70g, Flos Carthami 70g, Sanguis Draxonis 50g, Fructus Toosendan 70g, Rhizoma Curcumae 80g, Cornu Cervi Degelatinatum 40g, Pericarpium Citri Reticulatae Viride 60g, Rhizoma Bolbostematis 70g, Radix Phytolaccae 70g, Borneolum Syntheticum 25g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 2 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 80g, Myrrha 55g, Olibanum 55g, Radix Angelicae Sinensis 75g, Flos Carthami 75g, Sanguis Draxonis 45g, Fructus Toosendan 80g, Rhizoma Curcumae 90g, Cornu Cervi Degelatinatum 35g, Pericarpium Citri Reticulatae Viride 55g, Rhizoma Bolbostematis 75g, Radix Phytolaccae 65g, Borneolum Syntheticum 30g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
Embodiment 3 presses column weight amount weighting raw materials (unit: g)
Semen Vaccariae 95g, Myrrha 70g, Olibanum 70g, Radix Angelicae Sinensis 60g, Flos Carthami 65g, Sanguis Draxonis 55g, Fructus Toosendan 75g, Rhizoma Curcumae 85g, Cornu Cervi Degelatinatum 45g, Pericarpium Citri Reticulatae Viride 55g, Rhizoma Bolbostematis 65g, Radix Phytolaccae 75g, Borneolum Syntheticum 35g, laurocapram 15g, refined honey 220g, lanoline 120g, propylene glycol 80g.
The preparation method of above embodiment is:
Chinese crude drug respectively distinguish the flavor of in the prescription according to the clean system of regulation under Chinese Pharmacopoeia and this kind item of drug standard, the preparation method of plaster is: Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder are broken into fine powder (100 mesh sieve), mixing, for subsequent use; The decocting that Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate is concentrated into relative density 1.20~1.25(60 ℃) clear paste; Behind refined honey, lanoline, the propylene glycol heating and melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45~55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
Using method: local skin is affixed on breast after cleaning.Changed once in one to two day.Points for attention: the careful usefulness of skin allergy person.
Claims (1)
1. an external plaster for the treatment of cyclomastopathy is characterized in that being made by weight by following bulk drugs: 80~110 parts of Semen Vaccariae, 50~75 parts of Myrrhas, 50~75 parts of Olibanums, 60~80 parts of Radix Angelicae Sinensis, 60~80 parts on Flos Carthami, 40~55 parts of Sanguis Draxonis, 65~90 parts of Fructus Toosendans, 75~95 parts of Rhizoma Curcumae, 30~50 parts of Cornu Cervi Degelatinatums, 50~70 parts on Pericarpium Citri Reticulatae Viride, 60~80 parts of Rhizoma Bolbostematiss, 60~80 parts of Radix Phytolaccaes, 20~40 parts of Borneolum Syntheticums, 10~20 parts of laurocaprams, 150~250 parts of refined honeys, 100~250 parts of lanolines, 70~150 parts of propylene glycol;
The preparation method of above-mentioned plaster is: Semen Vaccariae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Rhizoma Curcumae, Pericarpium Citri Reticulatae Viride, Rhizoma Bolbostematis, Borneolum Syntheticum powder is broken into fine powder, crosses 100 mesh sieves, and mixing, for subsequent use; The decocting that Myrrha, Olibanum, Fructus Toosendan, Cornu Cervi Degelatinatum, Radix Phytolaccae add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate, relative density is 1.20~1.25 clear paste when being concentrated into 60 ℃; Behind refined honey, lanoline, the propylene glycol heating and melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat that temperature adds above-mentioned clear paste and stirs mixing when being down to 45~55 ℃; Add above-mentioned fine powder, stir, mixing, cream core processed, and place sticker, and get final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310006173.XA CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210045913.6 | 2012-02-27 | ||
CN2012100459136A CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
CN201310006173.XA CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103055263A true CN103055263A (en) | 2013-04-24 |
CN103055263B CN103055263B (en) | 2014-05-14 |
Family
ID=46469578
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100459136A Pending CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
CN201310006173.XA Active CN103055263B (en) | 2012-02-27 | 2013-01-08 | External use plaster for treating breast hyperplasia |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100459136A Pending CN102579977A (en) | 2012-02-27 | 2012-02-27 | External plaster for treating hyperplasia of mammary glands |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102579977A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106620525A (en) * | 2016-12-22 | 2017-05-10 | 苏祖荣 | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104586716A (en) * | 2013-10-31 | 2015-05-06 | 广州熹美生物科技有限公司 | Breast nursing cream |
CN112138106A (en) * | 2019-06-27 | 2020-12-29 | 河南省天施叶桂医药科技有限公司 | Method for preparing Chinese medicinal honey acupoint plaster |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116738A (en) * | 2006-08-01 | 2008-02-06 | 青岛市市立医院 | Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
CN101264266A (en) * | 2008-04-15 | 2008-09-17 | 尹伟 | Externally-applied paste for treating gland hyperplasia and preparation thereof |
CN101502580A (en) * | 2009-03-20 | 2009-08-12 | 汪世龙 | External-use medicament for treating tinea manus and pedis |
CN101564521A (en) * | 2009-05-20 | 2009-10-28 | 石振刚 | External plaster for treating hyperplasia of mammary glands |
CN102274450A (en) * | 2010-06-09 | 2011-12-14 | 买建修 | Breast pain syndrome dispersing paste |
-
2012
- 2012-02-27 CN CN2012100459136A patent/CN102579977A/en active Pending
-
2013
- 2013-01-08 CN CN201310006173.XA patent/CN103055263B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101116738A (en) * | 2006-08-01 | 2008-02-06 | 青岛市市立医院 | Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
CN101264266A (en) * | 2008-04-15 | 2008-09-17 | 尹伟 | Externally-applied paste for treating gland hyperplasia and preparation thereof |
CN101502580A (en) * | 2009-03-20 | 2009-08-12 | 汪世龙 | External-use medicament for treating tinea manus and pedis |
CN101564521A (en) * | 2009-05-20 | 2009-10-28 | 石振刚 | External plaster for treating hyperplasia of mammary glands |
CN102274450A (en) * | 2010-06-09 | 2011-12-14 | 买建修 | Breast pain syndrome dispersing paste |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106620525A (en) * | 2016-12-22 | 2017-05-10 | 苏祖荣 | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN102579977A (en) | 2012-07-18 |
CN103055263B (en) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
CN103055169B (en) | External use plaster for treating hypertensive disease | |
CN103330660B (en) | Skin-care health-care massage cream for waist and legs and preparation method thereof | |
CN104984316A (en) | Medicine for treating female cold in uterus | |
CN103055263B (en) | External use plaster for treating breast hyperplasia | |
CN100356964C (en) | Tendon-relaxing pain-relieving Chinese herbal powder | |
CN104367756A (en) | Traditional Chinese medicine composition for treating lumbar disc protrusion and preparation method thereof | |
CN102008698A (en) | Traditional Chinese medicine composition and preparation for curing dysmenorrhea | |
CN103977092B (en) | A kind of pharmaceutical composition for the treatment of myocardial infarction, cerebral infarction | |
CN103393943B (en) | Traditional Chinese medicine composition for treating sequela of cerebral infarction | |
CN103263627B (en) | Medicine for treating oblique inguinal hernia and preparation method thereof | |
CN102671180B (en) | Medicine for treating rheumatic lumbago and preparation method thereof | |
CN102038889B (en) | Traditional Chinese medicament for treating rheumatic heart disease | |
CN106552039A (en) | It is a kind of to cure root bone pain footbath with traditional Chinese medicines health care prescription | |
CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN104147382A (en) | Plaster for treating lumbago-leg pain | |
CN105687962A (en) | Electuary capable of treating atherosclerosis of coronary artery and preparation method thereof | |
CN108653704A (en) | A kind of lotion and preparation method thereof with anti-inflammatory analgetic function | |
CN103656050A (en) | Traditional Chinese medicine ointment for treating mammary gland hyperplasia and preparation method thereof | |
CN105497190A (en) | Traditional Chinese medicine fumigation pill and production technology thereof | |
CN104524454A (en) | Tinospora sinensis pain-relieving tincture | |
CN105497185A (en) | Chinese medicinal ointment for treating fracture | |
CN104491051A (en) | Traditional Chinese medicine preparation for recuperative medical care of chronic low back pains |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |